ELIZABETH BREWER: Open Payments
NPI 1528687159 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,602 in 118 payments from 13 companies in 2025. Trend: 2023 $1,855 · 2024 $1,971 · 2025 $2,602
Food & beverage: $2,415Education: $187
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $476 |
| E.R. Squibb & Sons, L.L.C. | 17 | $378 |
| Teva Pharmaceuticals USA, Inc. | 13 | $356 |
| Alkermes, Inc. | 12 | $259 |
| ABBVIE INC. | 18 | $258 |
| Neurocrine BioSciences, Inc. | 8 | $213 |
| Janssen Pharmaceuticals, Inc | 14 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $153 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Lundbeck LLC | 5 | $96 |
Products named: COBENFY, ARISTADA, VRAYLAR, FANAPT, HETLIOZ, INGREZZA, REXULTI, CAPLYTA.
Industry payments across TN — which companies pay providers there.
